thromboxanes has been researched along with Pulmonary Embolism in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badolia, R; Borst, O; Campbell, RA; Kunapuli, SP; Manne, BK; Middleton, E; Münzer, P; Rondina, MT; Walker-Allgaier, B; Weyrich, AS | 1 |
| Bao, ZY; Han, L; Li, M; Li, QY; Shi, GC; Wan, HY; Wang, X; Zhou, L | 1 |
| Battistini, B; Joo Kim, Y; Simon, M; Tsang, J | 1 |
| Hechtman, HB; Krausz, MM; Levine, L; Shepro, D; Utsonomiya, T | 1 |
| Jacobsen, DC | 1 |
| Hechtman, HB; Huval, WV; Mathieson, MA; Shepro, D; Stemp, LI; Valeri, CR | 1 |
| Copenhaver, G; Demers, LM; Luderer, JR; Reeves, WC; Skarlatos, S; Whitesell, L; Wood, MA | 1 |
| Landefeld, S | 1 |
| Burke, SE; Lefer, AM; Smith, JB | 1 |
| Dunham, B; Hechtman, HB; Krausz, MK; Levine, L; Shepro, D; Utsunomiya, T | 1 |
| Bizios, R; Garcia Szabo, RR; Johnson, A; Malik, AB; Minnear, FL | 1 |
| Ali, M; Cragg, DB; Forrest, JB; McDonald, JW; Todd, MH | 1 |
| Cohn, LS; Klotz, TA; Zipser, RD | 1 |
| Harasawa, M; Ishihara, Y; Kitamura, S; Kosaka, K | 1 |
| Kapsch, DN; Metzler, M; Silver, D | 1 |
| Cittadino, MH; Gordo, WM; Moreno, H; Tanus-Santos, JE; Udelsmann, A | 1 |
| Maruyama, Y; Mikashima, H; Muramoto, Y; Ochi, H; Tsuruta, M; Yasuda, H | 1 |
| Fukushima, M; Kobayashi, T; Kubo, K; Kusama, S | 1 |
3 review(s) available for thromboxanes and Pulmonary Embolism
| Article | Year |
|---|---|
Prostaglandins and cardiovascular disease--a review.
Topics: Arachidonic Acids; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Epoprostenol; Extracorporeal Circulation; Fetus; Homeostasis; Humans; Prostaglandin Antagonists; Prostaglandins; Pulmonary Embolism; Shock; Thromboxanes | 1983 |
Prostaglandin and thromboxane mediation of cardiopulmonary failure.
Topics: Animals; Arachidonic Acids; Cardiac Output; Cell Membrane; Cell Membrane Permeability; Dogs; Fibrinolysis; Humans; Indomethacin; Leukocytes; Lung; Plasminogen Activators; Platelet Aggregation; Prostaglandins; Pulmonary Edema; Pulmonary Embolism; Rats; Respiration, Artificial; Respiratory Insufficiency; Thromboxanes; Time Factors | 1983 |
Antithrombotic therapy for pulmonary embolism.
Topics: Animals; Anticoagulants; Fibrinolytic Agents; Heparin; Humans; Plasminogen Activators; Pulmonary Embolism; Thromboxanes | 1984 |
15 other study(ies) available for thromboxanes and Pulmonary Embolism
| Article | Year |
|---|---|
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Blood Platelets; Disease Models, Animal; Humans; Mice, Knockout; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-raf; Pulmonary Embolism; Pyrimidines; Signal Transduction; Thiophenes; Thrombosis; Thromboxanes | 2018 |
Effects of thrombolytic drugs and a selective endothelin-1 receptor antagonist on acute pulmonary thromboembolism in dogs.
Topics: Animals; Dogs; Endothelin A Receptor Antagonists; Endothelin-1; Fibrinolytic Agents; Peptides, Cyclic; Pulmonary Embolism; Random Allocation; Thromboxanes; Tumor Necrosis Factor-alpha | 2010 |
Plasma levels of endothelin-1, big endothelin-1 and thromboxane following acute pulmonary air embolism.
Topics: Acute Disease; Animals; Disease Models, Animal; Embolism, Air; Endothelin-1; Hemodynamics; Pulmonary Embolism; Random Allocation; Swine; Thromboxanes | 2003 |
Thromboxane mediation of cardiopulmonary effects of embolism.
Topics: Animals; Dogs; Epoprostenol; Female; Heart; Imidazoles; Indomethacin; Ketoconazole; Male; Piperazines; Platelet Count; Pulmonary Embolism; Thromboxane A2; Thromboxanes; Time Factors; Vascular Resistance | 1982 |
The release of thromboxane A2 and prostacyclin following experimental acute pulmonary embolism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blood Pressure; Epoprostenol; Kinetics; Male; Models, Biological; Prostaglandins; Pulmonary Artery; Pulmonary Embolism; Rabbits; Regional Blood Flow; Thromboxane A2; Thromboxane B2; Thromboxanes; Vascular Resistance | 1983 |
Role of thromboxanes and prostaglandin endoperoxides in the pathogenesis of eicosanoid induced sudden death.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Death, Sudden; Imidazoles; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins H; Pulmonary Embolism; Rabbits; Thromboxane A2; Thromboxanes; Vasoconstriction | 1983 |
Circulating negative inotropic agent(s) following pulmonary embolism.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Calcium-Transporting ATPases; Cardiac Output; Dogs; Epoprostenol; Indomethacin; Myocardial Contraction; Papillary Muscles; Pulmonary Embolism; Rats; Stroke Volume; Thromboxanes | 1982 |
Role of thromboxane in the pulmonary response to pulmonary microembolization.
Topics: Animals; Cell Adhesion; Imidazoles; Leukocyte Count; Leukocytes; Pulmonary Artery; Pulmonary Embolism; Sheep; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vascular Resistance | 1983 |
The involvement of prostaglandins and thromboxanes in the response to pulmonary embolism in anaesthetized rabbits and isolated perfused lungs.
Topics: 6-Ketoprostaglandin F1 alpha; Anesthesia, General; Animals; Aspirin; Hypotension; Indomethacin; Lung; Male; Perfusion; Pressure; Pulmonary Artery; Pulmonary Embolism; Rabbits; Thromboxane B2; Thromboxanes | 1983 |
Urinary excretion of thromboxane B2 in patients with venous thromboembolic disease.
Topics: Angiography; Aspirin; Humans; Lung; Platelet Function Tests; Pulmonary Embolism; Radioimmunoassay; Thrombophlebitis; Thromboxane B2; Thromboxanes | 1984 |
[Effect of hypoxemia and pulmonary thromboembolism on plasma levels of 6-keto PGF 1 alpha, TxB, histamine and serotonin in anesthetized dogs (author's transl)].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Dogs; Histamine; Hypoxia; Pulmonary Embolism; Serotonin; Thromboxane B2; Thromboxanes | 1981 |
Contributions of prostaglandin F2alpha and thromboxane A2 to the acute cardiopulmonary changes of pulmonary embolism.
Topics: Acute Disease; Animals; Blood Pressure; Cardiac Output; Dogs; Femoral Artery; Heart; Lung; Prostaglandins F; Pulmonary Artery; Pulmonary Embolism; Thromboxane A2; Thromboxanes | 1981 |
Nonselective endothelin-receptor antagonism attenuates hemodynamic changes after massive pulmonary air embolism in dogs.
Topics: Animals; Dogs; Embolism, Air; Endothelin Receptor Antagonists; Endothelin-1; Female; Hemodynamics; Male; Oligopeptides; Prospective Studies; Pulmonary Embolism; Thromboxanes | 2000 |
Effects of Y-20811, a long-lasting thromboxane synthetase inhibitor, on thromboxane production and platelet function.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Guinea Pigs; Humans; Imidazoles; In Vitro Techniques; Kinetics; Male; Microsomes; Platelet Aggregation; Platelet Count; Pulmonary Embolism; Rabbits; Seminal Vesicles; Sheep; Species Specificity; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1986 |
[Role of thromboxane A2 in pulmonary air embolism in conscious sheep].
Topics: Animals; Embolism, Air; Hemodynamics; Lymph; Methacrylates; Pulmonary Embolism; Sheep; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |